3000 Participants Needed
The Cleveland Clinic logo

Supervised Walking Assistance for Limited Mobility in Older Patients

Recruiting in Cleveland (>99 mi)
+4 other locations
MR
Overseen ByMichael Rothberg, M.D.
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The investigator proposes to conduct a randomized trial of supervised ambulation delivered by mobility technician (MT) up to three times daily, including weekends, to hospitalized medical patients. The aims of the study are to compare the short and intermediate-term outcomes of patients randomized to the intervention versus those patients randomized to receive usual care, to identify patients who are most likely to benefit from the intervention and to assess whether the intervention increases or decreases overall costs of an episode of care, including the cost of the MTs, the index hospitalization and the first 30 days post enrollment.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Mobility Technician-Assisted Ambulation for improving mobility in older patients?

Research shows that using Mobility Technicians (MTs) in hospitals helps older patients move more, which can lead to better recovery and shorter hospital stays. In one study, patients who received help from MTs were more likely to go home sooner and spent less time in the hospital, saving costs and improving hospital efficiency.12345

Is supervised walking assistance safe for older patients with limited mobility?

Research on devices similar to supervised walking assistance, like active assist transfer devices and robotic walkers, suggests they are generally safe. These devices have shown positive outcomes in terms of safety and satisfaction, although more rigorous studies are needed to confirm these findings.678910

How is the Mobility Technician-Assisted Ambulation treatment different from other treatments for limited mobility in older patients?

The Mobility Technician-Assisted Ambulation treatment is unique because it involves a supervised walking aid that partially relieves body weight, providing stability and facilitating movement for those with severe mobility issues. Unlike traditional walkers, this treatment includes a motorized, self-propelled mechanism that helps maintain step symmetry and reduces the physical effort required from the patient.1112131415

Research Team

MR

Michael Rothberg, M.D.

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

This trial is for people aged 65 or older who are admitted to a medical service, have completed necessary health checks, and have a certain level of mobility. They must be insured with Traditional Medicare or Medicare Advantage. It's not for those with significant language barriers (except Spanish at Baystate), planned discharges, upcoming surgeries, severe heart conditions, long-term nursing home residents, on comfort care only, admitted over 48 hours ago, or with active infections requiring isolation.

Inclusion Criteria

I am covered by Traditional Medicare or Medicare Advantage.
I am currently admitted to a hospital.
My mobility score is between 16 and 22.
See 2 more

Exclusion Criteria

I currently have an infection that requires isolation.
I cannot participate in exercise due to my unstable angina or other medical conditions.
Order for bedrest
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive supervised ambulation up to 3 times daily with a Mobility Technician (MT) until discharge or a maximum of 10 days

Up to 10 days
Daily visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of falls, physical function, and activities of daily living

30 days

Extended Follow-up

Assessment of total episode cost and frailty, including non-medication costs for 6 months post-enrollment

6 months

Treatment Details

Interventions

  • Mobility technician
Trial OverviewThe study tests if having a Mobility Technician help patients walk up to three times daily improves health outcomes compared to usual hospital care. The focus is on the benefits and costs during the hospital stay and the first month after joining the study.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobility TechnicianExperimental Treatment1 Intervention
Designated mobility technicians (MT) will ambulate hospitalized medical patients up to 3 times daily, 7 days per week, until discharge or a maximum of 10 days. Each day, the MT will visit the patient 4 times or until the patient successfully ambulates 3 times that day. In cases where a PT has provided a recommendation in the patient's chart, the MT will follow the recommendation, if feasible. Otherwise, the MT will execute the standard mobility protocol. The mobility protocol will allow the MT to assist a patient with an appropriate out-of-bed activity based on their 6-clicks score from the immediately preceding session
Group II: Usual CareActive Control1 Intervention
No intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

The AMBULATE study is a large randomized controlled trial involving older medical inpatients across five hospitals, aiming to assess the impact of mobility technicians (MTs) on improving mobility and reducing adverse events during hospitalization.
The study will evaluate key outcomes such as physical performance at discharge, hospital-acquired complications, and cost-effectiveness of employing MTs, potentially providing valuable insights into enhancing care for older adults in hospitals.
Assisted ambulation to improve health outcomes for older medical inpatients (AMBULATE): study protocol for a randomized controlled trial.Johnson, JK., Hamilton, AC., Hu, B., et al.[2023]
The introduction of mobility technicians (MTs) in a hospital setting significantly improved patient outcomes, with 79.7% of patients in the MT group discharged home compared to 66.1% in the control group, indicating enhanced recovery and mobility support.
Patients receiving MT services experienced a 2.4-day reduction in hospital stay and an estimated cost savings of $148,500 over six months, demonstrating the financial and operational benefits of this intervention.
Improving Discharge Rates to Home With the Help of Mobility Technicians: A Step in the Right Direction.Patel, SV., Imburgio, S., Johal, AS., et al.[2023]
The introduction of mobility technicians (MTs) in the care of patients undergoing total hip arthroplasty (THA) led to a higher percentage of patients being discharged home (91.51% vs. 87.43% in the control group), indicating improved recovery outcomes.
The use of MTs resulted in significant cost savings of approximately $119,794.50 annually for the hospital, suggesting that employing MTs can be financially beneficial while enhancing patient care during recovery.
Providing Patient Mobilization With a Mobility Technician Improves Staff Efficiency and Constrains Cost in Primary Total Hip Arthroplasty.Mazzei, CJ., Yurek, JW., Patel, JN., et al.[2021]

References

Assisted ambulation to improve health outcomes for older medical inpatients (AMBULATE): study protocol for a randomized controlled trial. [2023]
Improving Discharge Rates to Home With the Help of Mobility Technicians: A Step in the Right Direction. [2023]
Providing Patient Mobilization With a Mobility Technician Improves Staff Efficiency and Constrains Cost in Primary Total Hip Arthroplasty. [2021]
BOOSTing patient mobility and function on a general medical unit by enhancing interprofessional care. [2021]
Mobility Technicians: A Viable Solution to Early Ambulation of Total Joint Replacement Patients. [2021]
Assistive technology training: diverse audiences and multidisciplinary content. [2019]
Do active assist transfer devices improve transfer safety for patients and caregivers in hospital and community settings? A scoping review. [2021]
Intelligent walkers for the elderly: performance and safety testing of VA-PAMAID robotic walker. [2019]
Barriers and facilitators of assistive technology service delivery process (AT-SDP) in South Korea. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Further Development of a Robotic-Assisted Transfer Device. [2018]
Actual use of and satisfaction associated with rollators and "shopping carts" among frail elderly Japanese people using day-service facilities. [2018]
A walker with a device of partial suspension for patients with gait disturbance: body weight supported walker. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
A quality-of-life scale for assistive technology: results of a pilot study of aging and technology. [2021]
Self-propelled weight-relieving walker for gait rehabilitation. [2019]
A review of the functionalities of smart walkers. [2015]